Ngā hua rapu

Association of Choroidal Neovascularization and Central Serous Chorioretinopathy With Optical Coherence Tomography Angiography mā Marco A. Bonini Filho, Talisa E. de Carlo, Daniela Ferrara, Mehreen Adhi, Caroline R. Baumal, André J. Witkin, Elias Reichel, Jay S. Duker, Nadia K. Waheed

Whiwhi kuputuhi katoa

Interleukin‐18 Has Antipermeablity and Antiangiogenic Activities in the Eye: Reciprocal Suppression With VEGF mā Jikui Shen, David F. Choy, Tsunehiko Yoshida, Takeshi Iwase, Gulnar Hafiz, Bing Xie, Sean F. Hackett, Joseph R. Arron, Peter A. Campochiaro

Whiwhi kuputuhi katoa

Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Ophthalmic findingsSST report no. 11 mā Barbara S. Hawkins, Neil M. Bressler, Päivi H Miskala, Susan B. Bressler, Nancy M. Holekamp, Marta J. Marsh, Maryann Redford, Steven D. Schwartz, Paul W. Sternberg, M.A. Thomas, David J. Wilson

Whiwhi kuputuhi katoa

Macrophage polarization in the maculae of age-related macular degeneration: A pilot study mā Xiaoguang Cao, Defen Shen, Mrinali Patel, Jingsheng Tuo, T. Mark Johnson, Timothy W. Olsen, Chi‐Chao Chan

Whiwhi kuputuhi katoa

CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in a Mouse Model of Wet-Type Age-Related Macular Degeneration mā Nalini S. Bora, Sankaranarayanan Kaliappan, Purushottam Jha, Qin Xu, Baalasubramanian Sivasankar, Claire L. Harris, B. Paul Morgan, Puran S. Bora

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A Simple Optical Coherence Tomography Quantification Method for Choroidal Neovascularization mā Rania S. Sulaiman, Judith Quigley, Xiaoping Qi, Michael O’Hare, Maria B. Grant, Michael E. Boulton, Timothy W. Corson

Whiwhi kuputuhi katoa

Silibinin inhibits <scp>VEGF</scp> secretion and age‐related macular degeneration in a hypoxia‐dependent manner through the <scp>PI</scp>‐3 kinase/<scp>Akt</scp>/<scp>mTOR</scp> pa... mā Chien‐Huang Lin, CH Li, PL Liao, LS Tse, WK Huang, H‐W Cheng, YW Cheng

Whiwhi kuputuhi katoa

The Membrane Attack Complex in Aging Human Choriocapillaris mā Robert F. Mullins, Desi P. Schoo, Elliott H. Sohn, Miles J. Flamme‐Wiese, Grefachew Workamelahu, Rebecca M. Johnston, Kai Wang, Budd A. Tucker, Edwin M. Stone

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration mā Satyanarayana S Vedula, Wenjun Li

Whiwhi kuputuhi katoa

Optimization of an Image-Guided Laser-Induced Choroidal Neovascularization Model in Mice mā Yan Gong, Jie Li, Ye Sun, Zhongjie Fu, Chi‐Hsiu Liu, Lucy Evans, Katherine Tian, Nicholas Saba, Thomas Fredrick, Peyton Morss, Jing Chen, Lois E.H. Smith

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy mā Yedi Zhou, Shigeo Yoshida, Shintaro Nakao, Takeru Yoshimura, Yoshiyuki Kobayashi, Takahito Nakama, Yuki Kubo, Kohta Miyawaki, Muneo Yamaguchi, Keijiro Ishikawa, Yuji Oshima, Koichi Akashi, Tatsuro Ishibashi

Whiwhi kuputuhi katoa

Choroidal thickness and high myopia: a cross-sectional study and meta-analysis mā Shiming Wang, Yong Wang, Xiaoming Gao, Nana Qian, Youer Zhuo

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: Quality-of-life findingsSST report no. 12 mā Päivi H Miskala, Eric B Bass, Neil M. Bressler, Ashley L Childs, Barbara S. Hawkins, Carol M. Mangione, Marta J. Marsh

Whiwhi kuputuhi katoa

The Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration mā Davis, Ronald E. Gangnon, Lee Ly, Hubbard Ld, Klein Be, Ronald Klein, Frederick L. Ferris, Bressler Sb, R. C. Milton

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin mā Neil M. Bressler

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Verteporfin Therapy for Subfoveal Choroidal Neovascularization in Age-Related Macular Degeneration mā Mark S. Blumenkranz, Neil M. Bressler, Susan B Bressler, G. Donati, Gary E. Fish, Laurie Haynes, Hilel Lewis, Joan W. Miller, Jordi Monés, Michael J. Potter, Constantin J. Pournaras, Al Reaves, Philip J. Rosenfeld, Andrew Schachat, Ursula Schmidt‐Erfurth, Michel Sickenburg, Lawrence J. Singerman, Jason S. Slakter, Andrew T. Strong, Stéphane Vannier

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Pathologic myopia: where are we now?11Internet Advance publication at ajo.com Sept 17, 2002. mā Yasuo Tano

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD) mā Tsuyoshi Otsuji, Sho, Tsumura, Koike, Tsuda, Nishimura, Yasuo Takahashi, Nagaĭ

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Baseline Predictors for Good Versus Poor Visual Outcomes in the Treatment of Neovascular Age-Related Macular Degeneration With Intravitreal Anti-VEGF Therapy mā Bora Chae, Jesse J. Jung, Sarah Mrejen, Roberto Gallego‐Pinazo, Nicolas A. Yannuzzi, Samir Patel, Christine Y. Chen, Marcela Marsiglia, Sucharita Boddu, K. Bailey Freund

Whiwhi kuputuhi katoa

Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT) mā Gui‐shuang Ying, Maureen G. Maguire, Ebenezer Daniel, Frederick L. Ferris, Glenn J. Jaffe, Juan E. Grunwald, Cynthia A. Toth, Jiayan Huang, Daniel Martín

Whiwhi kuputuhi katoa